Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy

Por Espada, G, Giupponi, J, Cerqueiro, C
Publicado em 2011

Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center

Por Giupponi, Alvarez M, Guerini L, Meiorin SM, Espada G
Publicado em 2011-09-01

Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center

Por Espada, G, Meiorin, SM, Guerini, L, Alvarez, M, Giupponi
Publicado em 2011

Behcet Disease in pediatric Argentinian patients

Por Meiorin, S, Vega, C, Macias, E, Vargas, T Gonzalez, Espada, G
Publicado no Pediatr Rheumatol Online J (2015)

13.4 High frequency of CNS involvement in linear scleroderma of the face

Por Parolin, M, Russo, R, Corona, F, de Oliveira, SKF, Nowakowska, EM, Sztajnbok, F, Chaitow, J, Espada, G, Desjonqueres, M, Ullman, S, Zulian, F
Publicado em 2008

Therapeutic approaches for the treatment of new onset and flared juvenile systemic lupus erythematosus with active renal disease: an international multicenter PRINTO study

Por Miettunen, P, Pistorio, A, Ravelli, A, Oliveira, S, Alessio, M, Cuttica, R, Mihaylova, D, Espada, G, Pasic, S, Cortis, E, Ozen, S, Porras, O, Sztajnbok, F, Palmisani, E, Martini, A, Ruperto, N
Publicado em 2011

2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatme...

Por Ruperto, N, Lovell, DJ, Cuttica, R, Woo, P, Espada, G, Wouters, C, Silverman, ED, Balogh, Z, Henrickson, M, Davidson, J, Foeldvari, I, Imundo, L, Simonini, G, Oppermann, J, Shen, YK, Visvanathan, S, Fasanmade, A, Mendelsohn, A, Martini, A, Giannini, EH
Publicado em 2008

PW03-016 – Blau prospective cohort study: articular outcomes

Por Rose, CD, Cimaz, R, Thomee, C, Khubchandani, R, Espada, G, Russo, R, Harjacek, M, Bader-Meunier, B, Brissaud, P, Wulffraat, N, Vastert, S, Merino, R, Naranjo-Hernandez, A, Oliveira-Knupp, S, Mackensen, F, Arostegui, J, Anton, J, Fernandez-Martin, J, Wouters, C
Publicado em 2013

OR3-002 – Blau Syndrome cohort study: ocular outcome

Por Rose, CD, Cimaz, R, Thomee, C, Khubchandani, R, Espada, G, Russo, R, Harjacek, M, Bader-Meunier, B, Brissaud, P, Wulffraat, N, Vastert, S, Merino, R, Naranjo-Hernandez, A, Knupp, S Oliveira, Mackenson, F, Arostegui, J, Lopez, J Anton, Fernandez-Martin, J, Wouters, C
Publicado em 2013

PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey

Por Minoia, F, Davì, S, Horne, A, Consolaro, A, Rosina, S, Davidsone, Z, De Cunto, C, De Inocencio, J, Eisenstein, E, Espada, G, Fishbach, M, Frosch, M, Gallizzi, R, Gamir, ML, Griffin, T, Grom, A, Hennon, T, Horneff, G, Huasong, Z, Ruperto, N, Martini, A, Cron, RQ, Ravelli, A
Publicado em 2013

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data

Por De Benedetti, F, Brunner, H, Ruperto, N, Schneider, R, Woo, P, Burgos-Vargas, R, Dolezalova, P, Joos, R, Wulffraat, N, Zuber, Z, Zulian, F, Allen, R, Brown, D, Chaitow, J, Pardeo, M, Espada, G, Flato, B, Gerloni, V, Horneff, G, Wright, S, Kenwright, A, Lovell, D, Martini, A
Publicado em 2011

Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication?

Por Parodi, A, Davì, S, Pringe, AB, Magni-Manzoni, S, Miettunen, P, Bader-Meunier, B, Espada, G, Ozen, S, Wright, D, Magalhaes, C, Woo, P, Kubchandani, R, Grom, A, Michels, H, Wouters, C, Gutierrez, CE Toro, Sterba, G, Hayward, K, Guseinova, D, Fischer, A, Cortis, E, Vivarelli, M, Pistorio, A, Ruperto, N, Sala, I, Martini, A, Ravelli, A
Publicado em 2008